CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the pricing of 5,000,000 shares of outstanding common stock being offered by certain existing stockholders to the public at the price of $26.50 per share. CardioNet, Inc. will not receive any proceeds from the sale. The offer is expected to close on August 6, 2008. The selling stockholders have also granted to the underwriters a 30-day option to purchase from them an additional 750,000 shares to cover over-allotments, if any.
